Learn about OCREVUS ZUNOVO® (ocrelizumab & hyaluronidase-ocsq) subcutaneous injections and OCREVUS® (ocrelizumab) infusions. These prescription medicines are used for multiple sclerosis …

Oct 7, 2024 · Ocrevus (ocrelizumab) is a treatment for relapsing and progressive multiple sclerosis (MS) to help reduce relapses and slow disability progression. Ocrevus binds and destroys B cells, which …

Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti- CD20 monoclonal antibody. [8]

Dec 2, 2025 · Learn about side effects, cost, uses, and more of Ocrevus (ocrelizumab), an infusion that treats multiple sclerosis (MS) in adults.

Sep 26, 2024 · Find patient medical information for Ocrevus (ocrelizumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Feb 7, 2025 · Ocrevus (ocrelizumab) is an approved infusion therapy that’s indicated for adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting …

OCREVUS ZUNOVO® (ocrelizumab & hyaluronidase-ocsq) treats relapsing & primary progressive multiple sclerosis (RMS & PPMS). See full safety for more information.

Sep 23, 2024 · Ocrevus (Ocrelizumab Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …

OCREVUS is a humanized monoclonal antibody that is designed to target CD20-positive B cells. Although the exact way OCREVUS works is not known, it is thought to work in MS by decreasing …

Discover how OCREVUS ZUNOVO® (ocrelizumab & hyaluronidase-ocsq) and OCREVUS® (ocrelizumab) may help treat relapsing multiple sclerosis (RMS) or primary progressive multiple …